- Revance to Release Second Quarter 2021 Financial Results on Thursday, August 5, 2021
- Revance to Participate in Upcoming Virtual Healthcare Conferences
- Revance Provides Update on DaxibotulinumtoxinA for Injection Pre-Approval Inspection
- Revance Reports First Quarter 2021 Financial Results, Provides Corporate Update
As of last trade
Revance Therapeutics Inc (RVNC:NMQ) traded at 30.27, -12.58% below its 52-week high of 34.62, set on Sep 16, 2020.
22.89Nov 24 202034.62Sep 16 2020
Markit short selling activity
|Market cap||2.10bn USD|
|EPS (TTM)||-4.77 |
Data delayed at least 15 minutes, as of Aug 05 2021 17:18 BST.